

(Repeats Oct 2 story with no changes to text) * Drugmakers protect own medicines while challenging rivals * Drugmakers' last resort to wring exclusivi...


* Drugmakers protect own medicines while challenging rivals * Drugmakers' last resort to wring exclusivity from blockbusters * Novartis CEO predicts b...


(ShareCast News) - Close Brothers Group: Barclays reiterates overweight with a target price of 1500p. Royal Dutch Shell: HSBC keeps at buy, 2050p targ...


(ShareCast News) - Vodafone: HSBC reiterates buy with a target price of 280p. Melrose: UBS upgrades to buy, 200p target. Marks & Spencer: Deutsche Ba...


By Hillary Flynn NEW YORK, Sept 26 (IFR) - Seven investment-grade borrowers hit the US bond market on Monday, jumping into a shaky market watching for...


(ShareCast News) - N Brown: HSBC downgrades to hold with a target price of 205p. Kingfisher: UBS downgrades to neutral, 390p target. Morrison: Credit...


By Hillary Flynn NEW YORK, Sept 23 (IFR) - Investors piled into the debut bond from Shire this week, ignoring some clear warning signals that the drug...